Get started
Allarity Therapeutics, Inc.AA

Allarity Therapeutics, Inc.

1.05USDR
−0.02−1.87%
At close at May 9, 23:55 GMT
USD
No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

ALLR chart


Full chart

ALLR upcoming earnings


Next report date
≈
August 18
Report period
Q2 2025
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪17.93 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−708.97 USD
Net income (FY)
‪−24.52 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪13.05 M‬
Beta (1Y)
0.49

Employees


Employees (FY)
7
Change (1Y)
+1 +16.67%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−3.50 M‬ USD

About Allarity Therapeutics, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Thomas H. Jensen
Website
allarity.com
Headquarters
Boston
Founded
2021
FIGI
BBG012NXCZP8
Allarity Therapeutics, Inc. engages in the development of drugs for personalized treatment of cancer guided by its proprietary Drug Response Predictor (DRP) technology. The company operates in two geographic areas: Denmark and the United States. The company was founded on April 4, 2021 and is headquartered in Boston, MA.

Financials


Performance
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−12.00 M‬‬
‪‪−9.00 M‬‬
‪‪−6.00 M‬‬
‪‪−3.00 M‬‬
‪0.00‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−8.00 M‬‬
‪‪−6.00 M‬‬
‪‪−4.00 M‬‬
‪‪−2.00 M‬‬
‪0.00‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−8.00 M‬‬
‪‪−6.00 M‬‬
‪‪−4.00 M‬‬
‪‪−2.00 M‬‬
‪0.00‬
Debt level and coverage
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−8.00 M‬‬
‪0.00‬
‪‪8.00 M‬‬
‪‪16.00 M‬‬
‪‪24.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Earnings
Next:Aug 18, 2025
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
‪−10.00‬
‪−7.50‬
‪−5.00‬
‪−2.50‬
‪0.00‬
Actual
Estimate

ALLR news



No news here

Looks like there's nothing to report right now

Reload

Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ALLR is 1.05 USD — it has decreased by −1.87% in the past 24 hours. Watch Allarity Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Allarity Therapeutics, Inc. stocks are traded under the ticker ALLR.
ALLR stock has fallen by −11.76% compared to the previous week, the month change is a 45.81% rise, over the last year Allarity Therapeutics, Inc. has showed a −95.51% decrease.
ALLR reached its all-time high on Dec 21, 2021 with the price of 15,288,000.00 USD, and its all-time low was 0.61 USD and was reached on Apr 9, 2025. View more price dynamics on ALLR chart.
See other stocks reaching their highest and lowest prices.
ALLR stock is 5.83% volatile and has beta coefficient of 0.49. Track Allarity Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Allarity Therapeutics, Inc. there?
Today Allarity Therapeutics, Inc. has the market capitalization of ‪17.93 M‬, it has increased by 12.87% over the last week.
Yes, you can track Allarity Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Allarity Therapeutics, Inc. is going to release the next earnings report on Aug 18, 2025. Keep track of upcoming events with our Earnings Calendar.
ALLR net income for the last quarter is ‪−7.45 M‬ USD, while the quarter before that showed ‪−11.59 M‬ USD of net income which accounts for 35.69% change. Track more Allarity Therapeutics, Inc. financial stats to get the full picture.
No, ALLR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 10, 2025, the company has 7 employees. See our rating of the largest employees — is Allarity Therapeutics, Inc. on this list?
Like other stocks, ALLR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Allarity Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Allarity Therapeutics, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Allarity Therapeutics, Inc. stock shows the sell signal. See more of Allarity Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.